HomeCompareTTMZF vs MRK

TTMZF vs MRK: Dividend Comparison 2026

TTMZF yields 166666.67% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TTMZF wins by $7.944525992890705e+28M in total portfolio value
10 years
TTMZF
TTMZF
● Live price
166666.67%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$7.944525992890705e+28M
Annual income
$79,351,601,962,005,455,000,000,000,000,000,000.00
Full TTMZF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — TTMZF vs MRK

📍 TTMZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTTMZFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TTMZF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TTMZF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TTMZF
Annual income on $10K today (after 15% tax)
$14,166,666.67/yr
After 10yr DRIP, annual income (after tax)
$67,448,861,667,704,640,000,000,000,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, TTMZF beats the other by $67,448,861,667,704,640,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TTMZF + MRK for your $10,000?

TTMZF: 50%MRK: 50%
100% MRK50/50100% TTMZF
Portfolio after 10yr
$3.972262996445352e+28M
Annual income
$39,675,800,981,002,727,000,000,000,000,000,000.00/yr
Blended yield
99.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

TTMZF
No analyst data
Altman Z
-76.9
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TTMZF buys
0
MRK buys
0
No recent congressional trades found for TTMZF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTTMZFMRK
Forward yield166666.67%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$7.944525992890705e+28M$56.8K
Annual income after 10y$79,351,601,962,005,455,000,000,000,000,000,000.00$9,798.13
Total dividends collected$7.943912645651793e+28M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TTMZF vs MRK ($10,000, DRIP)

YearTTMZF PortfolioTTMZF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$16,677,367$16,666,666.67$11,206$366.19+$16.67MTTMZF
2$25,995,051,428$25,977,206,645.90$12,650$502.35+$25995.04MTTMZF
3$37,869,622,473,147$37,841,807,768,118.86$14,407$694.19+$37869622.46MTTMZF
4$51,562,007,868,526,340$51,521,487,372,480,070.00$16,585$967.82+$51562007868.51MTTMZF
5$65,615,852,892,511,920,000$65,560,681,544,092,600,000.00$19,342$1,363.89+$65615852892511.91MTTMZF
6$78,042,202,741,585,770,000,000$77,971,993,778,990,800,000,000.00$22,913$1,947.19+$78042202741585760.00MTTMZF
7$86,754,863,367,545,780,000,000,000$86,671,358,210,612,300,000,000,000.00$27,662$2,823.89+$86754863367545782272.00MTTMZF
8$90,137,108,986,090,100,000,000,000,000$90,044,281,282,286,820,000,000,000,000.00$34,159$4,173.35+$9.01371089860901e+22MTTMZF
9$87,530,810,188,407,730,000,000,000,000,000$87,434,363,481,792,600,000,000,000,000,000.00$43,337$6,308.80+$8.753081018840772e+25MTTMZF
10$79,445,259,928,907,045,000,000,000,000,000,000$79,351,601,962,005,455,000,000,000,000,000,000.00$56,776$9,798.13+$7.944525992890705e+28MTTMZF

TTMZF vs MRK: Complete Analysis 2026

TTMZFStock

Datable Technology Corporation, a technology company, provides consumer digital and social media engagement, data mining, and loyalty solutions primarily in Canada and the United States. The company offers PLATFORM³, a software as a service consumer marketing platform that enables consumer packaged goods companies and consumer brands to build and launch promotions and special offers on the mobile phone. It operates in consumer Internet advertising sector. The company was formerly known as 3Tl Technologies Corp. and changed its name to Datable Technology Corporation in May 2018. Datable Technology Corporation is headquartered in Vancouver, Canada.

Full TTMZF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this TTMZF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TTMZF vs SCHDTTMZF vs JEPITTMZF vs OTTMZF vs KOTTMZF vs MAINTTMZF vs JNJTTMZF vs ABBVTTMZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.